# Role of Genomic Imprinting in Cancer Diagnosis

> **NCT03882684** · — · UNKNOWN · sponsor: **Chinese Alliance Against Lung Cancer** · enrollment: 1500 (estimated)

## Conditions studied

- Early Diagnosis
- Cancer
- Biomarker
- Genomic Imprinting

## Interventions

- **DIAGNOSTIC_TEST:** In-situ imprinting detection

## Key facts

- **NCT ID:** NCT03882684
- **Lead sponsor:** Chinese Alliance Against Lung Cancer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-03-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2019-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882684, "Role of Genomic Imprinting in Cancer Diagnosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03882684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*